When nitrosamines are present in higher concentrations, and people are exposed to it for an extended period of time, there’s ...

An international team of researchers from the United States and Switzerland has identified chloronitramide anion as a ...

Detecting nitrosamines in pharmaceutical products is essential for maintaining safety and ensuring regulatory compliance.

The recalled lot may contain high levels of nitrosamines, a carcinogenic compound. The recall is Class II, meaning the health harms associated with taking the tainted medication are likely ...